Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study.

× No keyword cloud information.

5 in total

1. Lower mobility and markers of bone resorption in the elderly.

Authors: P Lips; F C van Ginkel; J C Netelenbos; A Wiersinga; W J van der Vijgh
Journal: Bone Miner Date: 1990-04

Review 2. Peak bone mass, bone loss and risk of fracture.

Authors: C C Johnston; C W Slemenda
Journal: Osteoporos Int Date: 1994 Impact factor: 4.507

3. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire.

Authors: T Pincus; J A Summey; S A Soraci; K A Wallston; N P Hummon
Journal: Arthritis Rheum Date: 1983-11

4. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

Authors: S R Cummings; M C Nevitt; W S Browner; K Stone; K M Fox; K E Ensrud; J Cauley; D Black; T M Vogt
Journal: N Engl J Med Date: 1995-03-23 Impact factor: 91.245

5. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Authors: A Hofman; D E Grobbee; P T de Jong; F A van den Ouweland
Journal: Eur J Epidemiol Date: 1991-07 Impact factor: 8.082

5 in total

39 in total

Review 1. Diagnosis of postmenopausal osteoporosis: reviews in endocrine and metabolic disorders.

Authors: A T Shields; C H Chesnut
Journal: Rev Endocr Metab Disord Date: 2001-01 Impact factor: 6.514

Review 2. Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?

Authors: M J Seibel
Journal: J Endocrinol Invest Date: 2003-05 Impact factor: 4.256

Review 3. Bone turnover markers: use in osteoporosis.

Authors: Kim Naylor; Richard Eastell
Journal: Nat Rev Rheumatol Date: 2012-06-05 Impact factor: 20.543

Review 4. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Authors: Serge Cremers; Patrick Garnero
Journal: Drugs Date: 2006 Impact factor: 9.546

Review 5. Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors: Aubrey Blumsohn
Journal: Curr Osteoporos Rep Date: 2003-12 Impact factor: 5.096

6. The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis (A-TOP) Research Group.

Authors: Masataka Shiraki; Tatsuhiko Kuroda; Toshitaka Nakamura; Masao Fukunaga; Takayuki Hosoi; Hajime Orimo; Kuniyoshi Makino
Journal: J Bone Miner Metab Date: 2006 Impact factor: 2.626

7. Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.

Authors: Mary L Bouxsein; Pierre D Delmas
Journal: J Bone Miner Res Date: 2008-08 Impact factor: 6.741

8. Socioeconomic status, race, and bone turnover in the Midlife in the US Study.

Authors: C J Crandall; D Miller-Martinez; G A Greendale; N Binkley; T E Seeman; A S Karlamangla
Journal: Osteoporos Int Date: 2011-08-03 Impact factor: 4.507

9. Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass.

Authors: S M Park; J Y Joung; Y Y Cho; S Y Sohn; K Y Hur; J H Kim; S W Kim; J H Chung; M K Lee; Y-K Min
Journal: Eur J Clin Nutr Date: 2015-02-04 Impact factor: 4.016

10. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.

Authors: P D Delmas; R R Recker; C H Chesnut; A Skag; J A Stakkestad; R Emkey; J Gilbride; R C Schimmer; C Christiansen
Journal: Osteoporos Int Date: 2004-04-08 Impact factor: 4.507